drugset / Trial / NCT00270777

Improving Safety of Antivenom in People Bitten by Snakes

NCT00270777

Phase 4 Completed 1000 enrolled University of Kelaniya
RandomizedFactorialDouble-blindTreatment

Summary

A study to increase the safety of polyvalent antivenom involving 1000 patients in three centres: low dose adrenaline, promethazine, \& hydrocortisone (alone and in combination) to prevent acute adverse reactions to antivenom in people bitten by snakes: randomised, double blind, placebo-controlled trial.

Timeline

Start
2005-03
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Epinephrine Other / unclassified 0.25 ml Subcutaneous
Subject Hydrocortisone Other / unclassified 200 mg Intravenous
Subject Promethazine Small molecule 25 mg Intravenous